Concepedia
Publication | Open Access
Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a)
63
Citations
17
References
2024
Year
ClinicalTrials.gov Identifier: NCT04606602.
Page 1